Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.

Published in:

British Journal of Dermatology, 2012, v. 167, n. 5, p. 1138, doi. 10.1111/j.1365-2133.2012.11186.x

By:

• Prey, S.;
• Ezzedine, K.;
• Doussau, A.;
• Grandoulier, A.-S.;
• Barcat, D.;
• Chatelus, E.;
• Diot, E.;
• Durant, C.;
• Hachulla, E.;
• de Korwin-Krokowski, J.-D.;
• Kostrzewa, E.;
• Quemeneur, T.;
• Paul, C.;
• Schaeverbeke, T.;
• Seneschal, J.;
• Solanilla, A.;
• Sparsa, A.;
• Bouchet, S.;
• Lepreux, S.;
• Mahon, F.-X.

Publication type:

Article